1. Home
  2. ITRN vs JANX Comparison

ITRN vs JANX Comparison

Compare ITRN & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ituran Location and Control Ltd.

ITRN

Ituran Location and Control Ltd.

HOLD

Current Price

$54.70

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$15.33

Market Cap

984.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRN
JANX
Founded
1994
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
984.3M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
ITRN
JANX
Price
$54.70
$15.33
Analyst Decision
Strong Buy
Buy
Analyst Count
3
13
Target Price
$60.67
$47.00
AVG Volume (30 Days)
139.0K
1.3M
Earning Date
05-26-2026
05-08-2026
Dividend Yield
3.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,000,000.00
Revenue This Year
$12.38
N/A
Revenue Next Year
$8.21
N/A
P/E Ratio
$16.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.71
$12.12
52 Week High
$68.30
$35.34

Technical Indicators

Market Signals
Indicator
ITRN
JANX
Relative Strength Index (RSI) 36.89 48.06
Support Level $47.78 $13.13
Resistance Level $68.00 $15.49
Average True Range (ATR) 1.96 0.61
MACD 0.00 -0.12
Stochastic Oscillator 19.63 4.80

Price Performance

Historical Comparison
ITRN
JANX

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: